Unlabelled: To further elucidate the significance of endocardial infiltrates in heart transplant patients, the presence, frequency, and type of endocardial infiltrates were evaluated in 5026 endomyocardial biopsy specimens obtained from 200 heart transplant patients 0 to 75 months after heart transplantation. The relationship of endocardial infiltrates to immunologic, clinical, and demographic variables was then explored. Endocardial infiltrates were detected in 557 endomyocardial biopsy specimens (11%) from 117 heart transplant patients (58%) at 6.3 +/- 9.4 months (mean +/- SD; range, 0 to 49 months) after heart transplantation. Heart transplant patients with endocardial infiltrates were younger (p = 0.03), had a greater incidence of idiopathic dilated cardiomyopathy before heart transplantation (p = 0.05), and included a greater percentage of females (p < 0.05). Both total and treated rejection rates were significantly higher in patients with endocardial infiltrates versus those without endocardial infiltrates (p = 0.0001). Rejection on the subsequent endomyocardial biopsies was more often present in endocardial biopsy specimens with endocardial infiltrates than in those without endocardial infiltrates, both in the presence (37% versus 24%; p < 0.001) and absence (33% versus 19%; p < 0.0001) of concomitant findings of rejection. No association was identified between endocardial infiltrates and posttransplantation lymphoproliferative disorder, cytomegalovirus infection, Epstein-Barr virus infection, or cardiac allograft vasculopathy. Multivariate regression analysis confirmed that the occurrence of endocardial infiltrates is associated with rejection when adjustment is made for patient's age, gender, heart disease before transplantation, follow-up time, and number of endomyocardial biopsies after heart transplantation (p = 0.0001).
Conclusions: (1) Endocardial infiltrates may occur with or without associated endomyocardial biopsy findings of rejection.(ABSTRACT TRUNCATED AT 250 WORDS)
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Pulmonary Artery Sarcoma with Extensive Invasion of the Right Ventricle: A Case Report and Review of Therapeutic Options.
Ann Thorac Cardiovasc Surg
November 2024
Department of Cardiovascular Surgery, Grand Hôpital de Charleroi, Charleroi, Belgium.
Pulmonary artery sarcoma (PAS) is a rare, aggressive cancer originating from the intimal layer of the pulmonary artery (PA), often mistaken for pulmonary thromboembolism. This case report underscores the complex management of PAS and the necessity of a multidisciplinary approach for accurate diagnosis and treatment. A 52-year-old woman with PAS was diagnosed using imaging and therapeutic tests to distinguish it from pulmonary embolism.
View Article and Find Full Text PDFIsavuconazonium sulfate induces heart development defects in zebrafish larvae by upregulation of oxidative stress.
Chem Biol Interact
December 2024
Affiliated Hospital of Jinggangshan University, Jiangxi Engineering Laboratory of Zebrafish Modeling and Drug Screening for Human Diseases, Jiangxi Key Laboratory of Developmental Biology of Organs and Epigenetics, Key Laboratory of Jiangxi Province for Biological Invasion and Biosecurity, Clinical Research Center of Affiliated Hospital of Jinggangshan University, College of Life Sciences, Jinggangshan University, 343009, Ji'an, China. Electronic address:
Article Synopsis
- Environmental pollution, particularly drug contamination, poses significant risks, with pharmaceutical compounds like Isavuconazonium sulfate (ISAV-SF) being detected in aquatic ecosystems at toxic levels.
- This study uses zebrafish to investigate the cardiotoxic effects of ISAV-SF, finding that exposure leads to serious heart development issues and disrupts key cardiac genes and signaling pathways.
- The antioxidant astaxanthin shows potential in reducing oxidative stress and improving heart development, highlighting the need for tighter regulations on ISAV-SF to protect aquatic life.
Report of a giant invasive, wall-penetrating cardiac lipoma.
J Cardiothorac Surg
October 2024
Department of Cardiovascular Surgery of the First Affiliated Hospital, Soochow University, Suzhou, Jiangsu, 215123, China.
Article Synopsis
- A cardiac lipoma is a rare, non-cancerous tumor found in the heart that can affect how the heart works.
- In this case, a 35-year-old man had a tumor that grew both inside and outside his right atrium, which was discovered through imaging tests.
- He had surgery to remove the tumor, and doctors confirmed it was a lipoma, with no problems found during a check-up three months later.
NASCI case of the month: 'Intramyocardial dissecting hematoma'.
Int J Cardiovasc Imaging
September 2024
Department of Radiology, Hacettepe University School of Medicine, Ankara, 06100, Turkey.
Article Synopsis
- Intramyocardial dissecting hematoma (IDH) happens when parts of the heart muscle get damaged because they don't get enough oxygen, often after a heart issue.
- The injury leads to a fluid buildup that can push against heart structures and may connect with other areas of the heart.
- Doctors can tell IDH apart from similar problems by checking if the heart walls are still intact and looking at how the blood flows in that area.
The innate immune regulator MyD88 dampens fibrosis during zebrafish heart regeneration.
Nat Cardiovasc Res
September 2024
Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
The innate immune response is triggered rapidly after injury and its spatiotemporal dynamics are critical for regeneration; however, many questions remain about its exact role. Here we show that MyD88, a key component of the innate immune response, controls not only the inflammatory but also the fibrotic response during zebrafish cardiac regeneration. We find in cryoinjured myd88 ventricles a significant reduction in neutrophil and macrophage numbers and the expansion of a collagen-rich endocardial population.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!